BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 1849710)

  • 1. Effects of ciprofloxacin on plasmid DNA supercoiling of Escherichia coli topoisomerase I and gyrase mutants.
    Aleixandre V; Herrera G; Urios A; Blanco M
    Antimicrob Agents Chemother; 1991 Jan; 35(1):20-3. PubMed ID: 1849710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Escherichia coli gyrA and gyrB mutations which have a graded effect on DNA supercoiling.
    Aleixandre V; Urios A; Herrera G; Blanco M
    Mol Gen Genet; 1989 Oct; 219(1-2):306-12. PubMed ID: 2559316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli.
    Bagel S; Hüllen V; Wiedemann B; Heisig P
    Antimicrob Agents Chemother; 1999 Apr; 43(4):868-75. PubMed ID: 10103193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. gyrB-225, a mutation of DNA gyrase that compensates for topoisomerase I deficiency: investigation of its low activity and quinolone hypersensitivity.
    Heddle JG; Lu T; Zhao X; Drlica K; Maxwell A
    J Mol Biol; 2001 Jun; 309(5):1219-31. PubMed ID: 11399091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance.
    Fisher LM; Lawrence JM; Josty IC; Hopewell R; Margerrison EE; Cullen ME
    Am J Med; 1989 Nov; 87(5A):2S-8S. PubMed ID: 2574005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of DNA gyrase inhibitors in Escherichia coli topoisomerase I mutants.
    Pruss GJ; Franco RJ; Chevalier SG; Manes SH; Drlica K
    J Bacteriol; 1986 Oct; 168(1):276-82. PubMed ID: 3019999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escherichia coli DNA topoisomerase I mutants: increased supercoiling is corrected by mutations near gyrase genes.
    Pruss GJ; Manes SH; Drlica K
    Cell; 1982 Nov; 31(1):35-42. PubMed ID: 6297751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discoordinate gene expression of gyrA and gyrB in response to DNA gyrase inhibition in Escherichia coli.
    Neumann S; Quiñones A
    J Basic Microbiol; 1997; 37(1):53-69. PubMed ID: 9090126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between DNA gyrase and quinolones: effects of alanine mutations at GyrA subunit residues Ser(83) and Asp(87).
    Barnard FM; Maxwell A
    Antimicrob Agents Chemother; 2001 Jul; 45(7):1994-2000. PubMed ID: 11408214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of topoisomerases in maintaining steady-state DNA supercoiling in Escherichia coli.
    Zechiedrich EL; Khodursky AB; Bachellier S; Schneider R; Chen D; Lilley DM; Cozzarelli NR
    J Biol Chem; 2000 Mar; 275(11):8103-13. PubMed ID: 10713132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of DNA topoisomerases involved in immediate and transient DNA relaxation induced by heat shock in Escherichia coli.
    Ogata Y; Mizushima T; Kataoka K; Miki T; Sekimizu K
    Mol Gen Genet; 1994 Sep; 244(5):451-5. PubMed ID: 8078472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activities of trovafloxacin compared with those of other fluoroquinolones against purified topoisomerases and gyrA and grlA mutants of Staphylococcus aureus.
    Gootz TD; Zaniewski RP; Haskell SL; Kaczmarek FS; Maurice AE
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1845-55. PubMed ID: 10428901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topoisomerase mutants and physiological conditions control supercoiling and Z-DNA formation in vivo.
    Jaworski A; Higgins NP; Wells RD; Zacharias W
    J Biol Chem; 1991 Feb; 266(4):2576-81. PubMed ID: 1846630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression in Escherichia coli of Y5 mutant and N-terminal domain-deleted DNA gyrase B proteins affects strongly plasmid maintenance.
    Brino L; Mousli M; Oudet P; Weiss E
    Plasmid; 1998; 39(1):21-34. PubMed ID: 9473443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gyrase inhibitors can increase gyrA expression and DNA supercoiling.
    Franco RJ; Drlica K
    J Bacteriol; 1989 Dec; 171(12):6573-9. PubMed ID: 2556367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypernegative supercoiling of the DNA template during transcription elongation in vitro.
    Drolet M; Bi X; Liu LF
    J Biol Chem; 1994 Jan; 269(3):2068-74. PubMed ID: 8294458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Escherichia coli DNA topoisomerase I mutants have compensatory mutations in DNA gyrase genes.
    DiNardo S; Voelkel KA; Sternglanz R; Reynolds AE; Wright A
    Cell; 1982 Nov; 31(1):43-51. PubMed ID: 6297752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA supercoiling in vivo.
    Giaever GN; Snyder L; Wang JC
    Biophys Chem; 1988 Feb; 29(1-2):7-15. PubMed ID: 2833949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [DNA supercoiling and topoisomerases in Escherichia coli].
    Gómez-Eichelmann MC; Camacho-Carranza R
    Rev Latinoam Microbiol; 1995; 37(3):291-304. PubMed ID: 8850348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topoisomerase IV, not gyrase, decatenates products of site-specific recombination in Escherichia coli.
    Zechiedrich EL; Khodursky AB; Cozzarelli NR
    Genes Dev; 1997 Oct; 11(19):2580-92. PubMed ID: 9334322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.